Third, we performed the subgroup analyses to effectively avoid the effects of heterogeneity and to explore the scope of application for TMPRSS2-ERG fusion as a predictive biomarker for PCa. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.